National Peroxide Reports ₹11 Cr Profit in FY26 After Turnaround

National Peroxide Ltd. announced its audited financial results for the fiscal year ended March 31, 2026, revealing a significant financial turnaround. The company posted a Profit After Tax (PAT) of ₹11.04 crore (₹1,103.71 lakh), a substantial recovery from a loss of ₹2.25 crore (₹-224.64 lakh) in the previous fiscal year (FY25).

Revenue from operations saw a modest increase, reaching ₹289.71 crore (₹28,971.14 lakh) in FY26, up from ₹286.87 crore (₹28,687.40 lakh) in FY25. Basic Earnings Per Share (EPS) for FY26 stood at ₹19.20.

Dividend and Leadership Changes

The company's board recommended a final dividend of ₹7 per equity share (70% of face value). This recommendation, along with the financial results, will be presented for shareholder approval at the upcoming Annual General Meeting (AGM).

In terms of key managerial personnel, Mr. Amit Goriwale is set to resign as Interim CFO & CRO effective May 31, 2026. The company has appointed Mr. Chirag Kothari as the new CFO & CRO, with his tenure beginning on June 1, 2026.

Financial Oversight and Governance

National Peroxide's statutory auditors issued an unmodified audit report on the financial results. A proposal to pay a commission of ₹17 lakh to Non-Executive Directors is subject to member approval, as it exceeds limits set by Section 197 of the Companies Act.

Why This Matters for Investors

This financial recovery is a positive signal for investors, demonstrating the company's ability to move from a loss-making position to profitability. The recommended dividend payout suggests management's confidence in sustained performance and a commitment to returning capital to shareholders.

The transition in the critical CFO & CRO roles is a key event. A smooth handover will be crucial for maintaining financial discipline and strategic direction, especially as the company builds on its recent performance.

Company Background and Sector Context

National Peroxide Ltd. manufactures Hydrogen Peroxide and Sodium Perborate from its facility in Maharashtra. The chemical sector experienced volatility, and challenging market conditions along with input cost pressures contributed to the company's loss in FY25. The improved FY26 results indicate a successful navigation of these difficulties and enhanced operational efficiency.

Shareholder Actions and Watchpoints

Shareholders will vote on the proposed final dividend and the commission payment to directors at the AGM. Investors will also closely monitor the transition of the Chief Financial Officer and Chief Risk Officer roles. The core takeaway is the company's improved financial health, moving from a net loss to a net profit.

Industry Performance

National Peroxide operates within a competitive chemical market. Peers such as GHCL Ltd. and Gujarat Fluorochemicals Ltd. have also reported strong performances. GHCL saw robust revenue growth in its chemical division in FY25, driven by Soda Ash demand, while Gujarat Fluorochemicals continues to expand its specialty chemicals business.

What to Track Next

Investors will be keen to see the outcomes of the AGM concerning the dividend and director commission. The performance of the new CFO & CRO, Mr. Chirag Kothari, will be closely watched as he guides the company's financial strategy. Future financial reports will be critical to determine if the FY26 profit is sustainable and if revenue growth continues, alongside overall market sentiment for Hydrogen Peroxide and related products.